Tor Biering-sørensen
Clinical trials sponsored by Tor Biering-sørensen, explained in plain language.
-
Could cheap supplements cut heart failure risks? large trial launches
Disease control Recruiting nowHeart failure is a serious condition with a poor outlook despite modern treatments. This large Danish trial will test whether two common supplements—coenzyme Q10 and selenium—can help. About 4,044 adults with heart failure will take either the supplements or placebos for 2-3 year…
Phase: PHASE3 • Sponsor: Tor Biering-Sørensen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Smart device alerts aim to cut heart failure hospitalizations
Disease control Recruiting nowThis study tests whether using alerts from a heart device (HeartLogic) can help manage heart failure better. About 1,428 adults with a compatible implanted device will be randomly assigned to have their care guided by these alerts or not. The goal is to see if this approach reduc…
Phase: NA • Sponsor: Tor Biering-Sørensen • Aim: Disease control
Last updated Jun 26, 2026 16:15 UTC
-
Shingles shot may shield seniors from heart attacks and dementia
Prevention Recruiting nowThis large study in Denmark is testing whether the shingles vaccine (Shingrix) can do more than prevent shingles—it may also lower the risk of heart attacks, strokes, and dementia. About 162,000 adults aged 65 and older will either get the vaccine or no vaccine, and researchers w…
Phase: PHASE4 • Sponsor: Tor Biering-Sørensen • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC